These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 323473)
1. Clinical trials of new drugs. Dollery CT J R Coll Physicians Lond; 1977 Apr; 11(3):226-33. PubMed ID: 323473 [No Abstract] [Full Text] [Related]
2. The case for recording events in clinical trials. Skegg DC; Doll R Br Med J; 1977 Dec; 2(6101):1523-4. PubMed ID: 338116 [TBL] [Abstract][Full Text] [Related]
3. Premarketing adverse drug experiences: data management procedures. Unexpected death occurring early in clinical trials. Cato A Drug Inf J; 1987; 21(1):3-7. PubMed ID: 10281637 [TBL] [Abstract][Full Text] [Related]
4. Statistical analyses of adverse event data from clinical trials. Special emphasis on serious events. O'Neill RT Drug Inf J; 1987; 21(1):9-20. PubMed ID: 10281640 [TBL] [Abstract][Full Text] [Related]
5. Benefit/risk ratio of new drugs: for whom? Discussion paper. Palminteri R J R Soc Med; 1988 Mar; 81(3):155-7. PubMed ID: 3282066 [No Abstract] [Full Text] [Related]
7. Data on drugs and adverse experiences: moving from the specific to the general. Windhorst DB; Pun EF; Zubkoff LA Drug Inf J; 1987; 21(1):39-46. PubMed ID: 10301495 [TBL] [Abstract][Full Text] [Related]
8. Talking about Toxicity - "What We've Got Here Is a Failure to Communicate". Sacks CA; Miller PW; Longo DL N Engl J Med; 2019 Oct; 381(15):1406-1408. PubMed ID: 31597018 [No Abstract] [Full Text] [Related]
9. Epidemiological observation on drug-induced illness. Jick H Curr Top Pathol; 1980; 69():1-15. PubMed ID: 7016466 [No Abstract] [Full Text] [Related]
11. Letter: Clinical evaluation of side-effects of drugs. Bam WJ; de Wet BS S Afr Med J; 1973 Sep; 47(36):1624. PubMed ID: 4746965 [No Abstract] [Full Text] [Related]
12. [Problems of individual pharmacotherapy in modern cardiology]. Metelitsa VI Kardiologiia; 1978 Mar; 18(3):5-11. PubMed ID: 347138 [No Abstract] [Full Text] [Related]
13. Population-based studies of adverse drug effects. Ray WA N Engl J Med; 2003 Oct; 349(17):1592-4. PubMed ID: 14573730 [No Abstract] [Full Text] [Related]
14. Monitoring adverse reactions to drugs. Br Med J; 1977 Feb; 1(6058):439. PubMed ID: 837141 [No Abstract] [Full Text] [Related]
15. Monitoring adverse reactions to drugs. Pearson R Br Med J; 1977 Apr; 1(6069):1159. PubMed ID: 861519 [No Abstract] [Full Text] [Related]
16. Monitoring of drugs after marketing. J R Coll Gen Pract; 1983 Jul; 33(252):438-41. PubMed ID: 6887114 [No Abstract] [Full Text] [Related]
17. The methodology of safety data in clinical trials. Stephens MD Bratisl Lek Listy; 1991 Nov; 92(11):544-5. PubMed ID: 1806165 [TBL] [Abstract][Full Text] [Related]
18. Drug hepatotoxicity from a regulatory perspective. Senior JR Clin Liver Dis; 2007 Aug; 11(3):507-24, vi. PubMed ID: 17723917 [TBL] [Abstract][Full Text] [Related]
19. Abstracts of the symposium on safety evaluation of drugs and chemicals. June 1-3, 1981, Iowa State University, Ames, Iowa. Vet Hum Toxicol; 1981 Oct; 23(5):344-9. PubMed ID: 6117147 [No Abstract] [Full Text] [Related]
20. The way towards adverse event monitoring in clinical trials. Wallander MA Drug Saf; 1993 Mar; 8(3):251-62. PubMed ID: 8452665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]